Estadisticas : Fluorouracil, Doxorubicin, and Cyclophosphamide (FAC) Versus FAC Followed by Weekly Paclitaxel As Adjuvant Therapy for High-Risk, Node-Negative Breast Cancer: Results From the GEICAM/2003-02 Study

Martín, Miguel
Visitas:293

154 ( Estados Unidos de América )

53 ( Hong kong )

23 ( Brasil )

15 ( Singapur )

8 ( Letonia )

7 ( Irlanda )

4 ( España )

3 ( Alemania )

3 ( China )

3 ( Vietnam )

2 ( Jordania )

2 ( Reino Unido )

2 ( Ucrania )

1 ( Bangladesh )

1 ( Francia )

1 ( Bulgaria )

1 ( Venezuela )

1 ( Países Bajos )

1 ( Dominica )

1 ( Canadá )

1 ( Ecuador )

1 ( Argentina )

1 ( India )

1 ( Azerbaiyán )

1 ( Marruecos )

1 ( México )

1 ( Austria )

Descargas: 0